Altimmune, Inc.ALTNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P13
Within normal range
vs 2Y Ago
-3.3x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -63.47% |
| Q3 2025 | 39.45% |
| Q2 2025 | -16.67% |
| Q1 2025 | 7.80% |
| Q4 2024 | 32.65% |
| Q3 2024 | -49.76% |
| Q2 2024 | -10.70% |
| Q1 2024 | 1.06% |
| Q4 2023 | 19.30% |
| Q3 2023 | -4.71% |
| Q2 2023 | -0.81% |
| Q1 2023 | -12.14% |
| Q4 2022 | -14.99% |
| Q3 2022 | 9.90% |
| Q2 2022 | -23.50% |
| Q1 2022 | 38.43% |
| Q4 2021 | -23.58% |
| Q3 2021 | 6.09% |
| Q2 2021 | 3.28% |
| Q1 2021 | -45.89% |
| Q4 2020 | -41.12% |
| Q3 2020 | -32.55% |
| Q2 2020 | -64.95% |
| Q1 2020 | -117.15% |
| Q4 2019 | 17.50% |
| Q3 2019 | 20.70% |
| Q2 2019 | -44.83% |
| Q1 2019 | 59.02% |
| Q4 2018 | -403.97% |
| Q3 2018 | -393.83% |
| Q2 2018 | 109.78% |
| Q1 2018 | 25.96% |
| Q4 2017 | -12.85% |
| Q3 2017 | -5.05% |
| Q2 2017 | 42.87% |
| Q1 2017 | -108.56% |
| Q4 2016 | -25.66% |
| Q3 2016 | 1205.24% |
| Q2 2016 | 730.15% |
| Q1 2016 | 25.91% |